國立虎尾科技大學 |

Significant pharmaceuticals reported in recent US patents

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Significant pharmaceuticals reported in recent US patents/ Thomas F. DeRosa.
作者:	DeRosa, Thomas F.
出版者:	Amsterdam ;Elsevier, : 2007.,
面頁冊數:	xx, 680 p. :ill. ; : 25 cm.;
附註:	Includes index.
標題:	Drugs - Research - United States. -
電子資源:	An electronic book accessible through the World Wide Web; click for information
ISBN:	9780080453446

Significant pharmaceuticals reported in recent US patents
DeRosa, Thomas F.

Significant pharmaceuticals reported in recent US patents[electronic resource] /Thomas F. DeRosa. - Amsterdam ;Elsevier,2007. - xx, 680 p. :ill. ;25 cm.

Includes index.

Acquired Immune Deficiency Syndrome -- Addiction Disorders -- Alzheimer's Disease -- Analgesics -- Antibacterial Agents -- Anti-inflammatory Agents -- Autoimmune Disorders -- Cardiovascular Disorders -- Diabetes -- Diagnostics -- Epilepsy -- Gastrointestional Disorders -- Hepatitis C -- Hormonal Disorders -- Immunosuppressants -- Improved Synthetic Methods -- Incontinence -- Irritable Bowel Syndrome -- Osteoporosis -- Malaria -- Migraine Headaches -- Obesity -- Proliferative Disorders -- Skin Disorders -- Sleep Disorders -- Thyroid Disorders -- Tinnitus.

This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including; AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. * Identifies next generation pharmaceuticals * Provides practical preparation methods for each active agent and derivatives * Documents the analytical characterization and biological testing results of active agents.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.

Mode of access: World Wide Web.

ISBN: 9780080453446

Source: 133781:133907Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

791579
Drugs
--Research--United States.Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: RM301.25 / .D47 2007

Dewey Class. No.: 615.1900973

Significant pharmaceuticals reported in recent US patents
LDR:03482cam 2200313Ia 4500 001 680135
003 OCoLC
005 20110615082928.0
006 m d
007 cr cn|||||||||
008 111108s2007 ne a o 001 0 eng d
020 $a 9780080453446
020 $a 0080453449
029 1 $a NZ1 $b 11778308
035 $a (OCoLC)162131457
035 $a ocn162131457
037 $a 133781:133907 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $c OPELS $d OPELS
049 $a TEFA
050 1 4 $a RM301.25 $b .D47 2007
082 0 4 $a 615.1900973 $2 22
100 1 $a DeRosa, Thomas F. $3 791578
245 1 0 $a Significant pharmaceuticals reported in recent US patents $h [electronic resource] / $c Thomas F. DeRosa.
260 $a Amsterdam ; $a London : $b Elsevier, $c 2007.
300 $a xx, 680 p. : $b ill. ; $c 25 cm.
500 $a Includes index.
505 0 $a Acquired Immune Deficiency Syndrome -- Addiction Disorders -- Alzheimer's Disease -- Analgesics -- Antibacterial Agents -- Anti-inflammatory Agents -- Autoimmune Disorders -- Cardiovascular Disorders -- Diabetes -- Diagnostics -- Epilepsy -- Gastrointestional Disorders -- Hepatitis C -- Hormonal Disorders -- Immunosuppressants -- Improved Synthetic Methods -- Incontinence -- Irritable Bowel Syndrome -- Osteoporosis -- Malaria -- Migraine Headaches -- Obesity -- Proliferative Disorders -- Skin Disorders -- Sleep Disorders -- Thyroid Disorders -- Tinnitus.
520 $a This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including; AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. * Identifies next generation pharmaceuticals * Provides practical preparation methods for each active agent and derivatives * Documents the analytical characterization and biological testing results of active agents.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2007. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on July 25, 2007). $n Access may be restricted to users at subscribing institutions.
650 0 $a Drugs $x Research $z United States. $3 791579
650 0 $a Drugs $z United States $x Patents. $3 791580
650 0 $a Drug development $z United States. $3 583248
655 7 $a Electronic books. $2 local $3 554714
710 2 $a ScienceDirect (Online service) $3 636041
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780080453446 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF